Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.

Abstract

Fifteen patients fulfilling DSM-IV criteria for major depression were investigated with the specific dopamine D2 receptor antagonist [123I]iodobenzamide (IBZM). Two single photon emission computed tomography (SPECT) examinations were performed before and after 6 weeks of treatment with a selective serotonin re-uptake inhibitor (SSRI). Striatal D2 receptor… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.